Bradmer Pharmaceuticals Inc. Announces Grant of Options to Directors and Officers

(firmenpresse) - TORONTO, ONTARIO -- (Marketwire) -- 07/21/11 -- Bradmer Pharmaceuticals Inc. (TSX VENTURE: BMR.H) announced today that it has granted, subject to regulatory approval, options to directors and officers of the company exercisable to acquire an aggregate of 1,500,000 common shares, at a price of $0.10 per share, expiring July 21, 2021.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.



Contacts:
Bradmer Pharmaceuticals Inc.
Paul Van Damme
416.987.6113

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 21.07.2011 - 20:05 Uhr
Sprache: Deutsch
News-ID 36895
Anzahl Zeichen: 0

contact information:
Town:

TORONTO, ONTARIO

Kategorie:

Biotech

Diese Pressemitteilung wurde bisher 166 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Bradmer Pharmaceuticals Inc. Announces Grant of Options to Directors and Officers"
steht unter der journalistisch-redaktionellen Verantwortung von

Bradmer Pharmaceuticals Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Bradmer Announces Third Quarter 2017 Financial and Operational Results ...

TORONTO, ONTARIO -- (Marketwired) -- 11/06/17 -- Bradmer Pharmaceuticals Inc. (NEX: BMR.H) ("Bradmer" or the "Company") today announced its third quarter 2017 financial results.Financial ResultsAmounts in US dollars, unless spec ...

Bradmer Announces Second Quarter 2017 Financial Results ...

TORONTO, ONTARIO -- (Marketwired) -- 08/01/17 -- Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") (NEX: BMR.H) today announced its second quarter 2017 financial results.Financial ResultsAmounts in US dollars, unless spe ...

Bradmer Announces First Quarter 2017 Financial Results ...

TORONTO, ONTARIO -- (Marketwired) -- 05/15/17 -- Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") (NEX: BMR.H) today announced its first quarter 2017 financial results.Financial ResultsAmounts in US dollars, unless spec ...

Alle Meldungen von Bradmer Pharmaceuticals Inc.